Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Chih Yang

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Clinical and Experimental Rheumatology|June 10, 2024
Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virusTing-Yuan Lan, Ting-Wei Chang, Tai-Chung Tseng, et al.
Journal of Hepatology|March 20, 2018
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infectionHung-Chih Yang, Hsiao-Hui Tsou, Sung-Nan Pei, et al.
Hepatology (Baltimore, Md.)|September 4, 2012
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loadsTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
The American Journal of Gastroenterology|August 31, 2017
Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular CarcinomaTai-Chung Tseng, Chun-Jen Liu, Tung-Hung Su, et al.
The Journal of Infectious Diseases|May 10, 2013
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkersTai-Chung Tseng, Chun-Jen Liu, Chi-Ling Chen, et al.
Journal of Gastroenterology and Hepatology|January 4, 2014
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconvertersTai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, et al.
Molecular Therapy. Methods & Clinical Development|April 26, 2021
Robust induction of T<sub>RM</sub>s by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza virusesPin-Hung Lin, Chieh-Yu Liang, Bing-Yu Yao, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTung-Hung Su, Sih-Han Liao, Chun-Ming Hong, et al.
The American Journal of Gastroenterology|February 22, 2022
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate PhaseTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 20, 2022
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccinationWang-Huei Sheng, Sui-Yuan Chang, Pin-Hung Lin, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Rheumatology|June 10, 2024
Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virusTing-Yuan Lan, Ting-Wei Chang, Tai-Chung Tseng, et al.
Journal of Hepatology|March 20, 2018
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infectionHung-Chih Yang, Hsiao-Hui Tsou, Sung-Nan Pei, et al.
Hepatology (Baltimore, Md.)|September 4, 2012
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loadsTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
The American Journal of Gastroenterology|August 31, 2017
Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular CarcinomaTai-Chung Tseng, Chun-Jen Liu, Tung-Hung Su, et al.
The Journal of Infectious Diseases|May 10, 2013
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkersTai-Chung Tseng, Chun-Jen Liu, Chi-Ling Chen, et al.
Journal of Gastroenterology and Hepatology|January 4, 2014
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconvertersTai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, et al.
Molecular Therapy. Methods & Clinical Development|April 26, 2021
Robust induction of T<sub>RM</sub>s by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza virusesPin-Hung Lin, Chieh-Yu Liang, Bing-Yu Yao, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTung-Hung Su, Sih-Han Liao, Chun-Ming Hong, et al.
The American Journal of Gastroenterology|February 22, 2022
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate PhaseTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 20, 2022
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccinationWang-Huei Sheng, Sui-Yuan Chang, Pin-Hung Lin, et al.
Pageof 15